Navigation Links
Treatment for chemobrain may be possible

Cancer patients may rejoice as researchers have developed a treatment to treat// the condition called “chemobrain” in cancer survivors.

People who suffer from cancer and had to undergo chemotherapy often find the process of treatment affecting their mental functions and cognitive abilities. This condition is called chemobrain and some common symptoms are inability to concentrate, inability to be organized in doing daily activities, inability to think clearly and loss of memory.

Researchers from University of Cincinnati have discovered a possible treatment for this condition with the help of the drug dexmethyphenidate (d-MPH). The researchers report that the phase II study of the drug on the condition of chemobrain had been quite successful.

Researchers had reported that 154 cancer survivors in different medical centers have reported significant improvement in their conditions like lessening of fatigue, and increasing memory when treated with 10 mg to 50 mg of the drug d-MPH per day. All the participants of the study had completed four circles of chemotherapy when the drug d-MPH were prescribed and administered to them. Researchers confirmed that their study had shown the drug to be safe and effective to be prescribed to treat “chemobrain “ conditions to patients who need help.

The report was presented at the annual meeting of the American Society of Clinical Oncology this yar.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... Researchers from ... protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The data, ... (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event rates ...
(Date:5/24/2016)... LONGMONT, CO (PRWEB) , ... ... ... Essette’s official announcement of Essette Dashboard, its highly anticipated, web-based software module. ... visualization platform. The application’s “secret sauce”? Integration with Izenda’s self-service business intelligence ...
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, ... new $11.5 million, 64-room assisted living center. After 18 months of construction, the ... , The new building provides the latest in assisted living amenities and services, ...
(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... and sexual objectification, according to Georgia State University researchers. , In ... in the fifth, sixth and seventh grades shared their experiences with strained ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... According to a new market research report "Sunitinib Malate ... Germany , France , U.K., ... Japan )", published by MarketsandMarkets, The market is projected to ... from 2016 to 2021.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ... through 26 Pages and in-depth TOC on "Sunitinib Malate ...
(Date:5/19/2016)... , May 19, 2016 , The ... (a bstract # 8006)   The ... of the treated patients with 90% of the ... six months or more . Seventy two percent of the patients had ... (MSE:PHM) announces the positive results from a Phase I study of plitidepsin in ...
(Date:5/19/2016)... NEW YORK , May 19, 2016 ... one sector that is always abounding of surprises is without ... the Healthcare sector ahead of today,s trading session: Alkermes PLC ... AMAG ), IDEXX Laboratories Inc. (NASDAQ: IDXX ... Sign up for your complimentary alerts at: ...
Breaking Medicine Technology: